Ethical and practical considerations arising from community consultation on implementing controlled human infection studies using Schistosoma mansoni in Uganda
- PMID: 35814190
- PMCID: PMC9258062
- DOI: 10.1080/11287462.2022.2091503
Ethical and practical considerations arising from community consultation on implementing controlled human infection studies using Schistosoma mansoni in Uganda
Abstract
Issues related to controlled human infection studies using Schistosoma mansoni (CHI-S) were explored to ensure the ethical and voluntary participation of potential CHI-S volunteers in an endemic setting in Uganda. We invited volunteers from a fishing community and a tertiary education community to guide the development of informed consent procedures. Consultative group discussions were held to modify educational materials on schistosomiasis, vaccines and the CHI-S model and similar discussions were held with a test group. With both groups, a mock consent process was conducted. Fourteen in-depth key informant interviews and three group discussions were held to explore perceptions towards participating in a CHI-S. Most of the participants had not heard of the CHI-S. Willingness to take part depended on understanding the study procedures and the consenting process. Close social networks were key in deciding to take part. The worry of adverse effects was cited as a possible hindrance to taking part. Volunteer time compensation was unclear for a CHI-S. Potential volunteers in these communities are willing to take part in a CHI-S. Community engagement is needed to build trust and time must be taken to share study procedures and ensure understanding of key messages.
Keywords: Controlled human infection; endemic; informed consent; perceptions; schistosomiasis.
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures
Similar articles
-
Ethical and scientific considerations on the establishment of a controlled human infection model for schistosomiasis in Uganda: report of a stakeholders' meeting held in Entebbe, Uganda.AAS Open Res. 2018 Aug 6;1:2. doi: 10.12688/aasopenres.12841.2. eCollection 2018. AAS Open Res. 2018. PMID: 30714021 Free PMC article.
-
Risk assessment for the implementation of controlled human Schistosoma mansoni infection trials in Uganda.AAS Open Res. 2019 Aug 13;2:17. doi: 10.12688/aasopenres.12972.2. eCollection 2019. AAS Open Res. 2019. PMID: 31819922 Free PMC article.
-
Perceptions about interventions to control schistosomiasis among the Lake Victoria island communities of Koome, Uganda.PLoS Negl Trop Dis. 2017 Oct 2;11(10):e0005982. doi: 10.1371/journal.pntd.0005982. eCollection 2017 Oct. PLoS Negl Trop Dis. 2017. PMID: 28968470 Free PMC article.
-
Volunteer experiences and perceptions of the informed consent process: Lessons from two HIV clinical trials in Uganda.BMC Med Ethics. 2015 Dec 3;16(1):86. doi: 10.1186/s12910-015-0073-1. BMC Med Ethics. 2015. PMID: 26630924 Free PMC article. Review.
-
Health-seeking behaviour regarding schistosomiasis treatment in the absence of a mass drug administration (MDA) program: the case of endemic communities along Lake Albert in Western Uganda.BMC Public Health. 2023 Jun 5;23(1):1072. doi: 10.1186/s12889-023-16020-z. BMC Public Health. 2023. PMID: 37277773 Free PMC article. Review.
Cited by
-
Recruitment strategies used to enrol healthy volunteers in the first pneumococcal human infection study in Africa: Lessons from Blantyre, Malawi.Wellcome Open Res. 2025 Feb 26;9:216. doi: 10.12688/wellcomeopenres.19271.2. eCollection 2024. Wellcome Open Res. 2025. PMID: 40191101 Free PMC article.
-
Identification of training needs in schistosomiasis research to build capacity for schistosomiasis control in Uganda.Trop Med Int Health. 2025 Apr;30(4):314-321. doi: 10.1111/tmi.14098. Epub 2025 Feb 28. Trop Med Int Health. 2025. PMID: 40018823 Free PMC article.
-
Establishing a single-sex controlled human Schistosoma mansoni infection model for Uganda: protocol for safety and dose-finding trial.Immunother Adv. 2023 Jul 20;3(1):ltad010. doi: 10.1093/immadv/ltad010. eCollection 2023. Immunother Adv. 2023. PMID: 37538934 Free PMC article.
-
Perceptions and acceptability of the controlled human malaria infection (CHMI) model in The Gambia: a qualitative study.Sci Rep. 2023 May 29;13(1):8708. doi: 10.1038/s41598-023-35752-x. Sci Rep. 2023. PMID: 37248260 Free PMC article.
-
Helminth infection and helminth-derived products: A novel therapeutic option for non-alcoholic fatty liver disease.Front Immunol. 2022 Oct 3;13:999412. doi: 10.3389/fimmu.2022.999412. eCollection 2022. Front Immunol. 2022. PMID: 36263053 Free PMC article. Review.
References
-
- Alabi, A., Hussain, M., Hoogerwerf, M.-A., Mengome, C. N., Egesa, M., Driciru, E., Wammes, L. J., Kruize, Y. C. M., Sartono, E., Adegnika, A. A., Kremsner, P. G., Yazdanbakhsh, M., & Agnandji, S. T. (2021). Establishing a controlled hookworm human infection (CHHI) model for Africa: A report from the stakeholders meeting held in Lambaréné, Gabon, November 10–11, 2019. Archives of Public Health, 79(1), 120. 10.1186/s13690-021-00650-z - DOI - PMC - PubMed
-
- Alden, D. L., Friend, J., Lee, P. Y., Lee, Y. K., Trevena, L., Ng, C. J., Kiatpongsan, S., Lim Abdullah, K., Tanaka, M., & Limpongsanurak, S. (2018). Who decides: Me or We? Family involvement in medical decision making in Eastern and Western countries. Medical Decision Making, 38(1), 14–25. 10.1177/0272989X17715628 - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources